Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 5, 2007, Pages 627-635

  Miyamoto, Yoshiaki ^a   Suyama, Takashi ^a   Yashita, Tomoko ^a   Akimaru, Hiroshi ^a   Kurata, Hirokazu ^a  

^a Cardio Inc   (Japan)

Author keywords

Angiogenesis; Bone marrow; Cytokines; Endothelial progenitor; Neovascularization

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CD11B ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SCATTER FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMUR; FLOW CYTOMETRY; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS;

EID: 35448954459     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.08.001     Document Type: Article

References (41)

1. Hristov M., and Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8 (2004) 498-508
2. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115 (2005) 572-583
3. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
4. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
5. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
6. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ. Res. 96 (2005) 151-163
7. Forrester J.S., Price M.J., and Makkar R.R. Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation 108 (2003) 1139-1145
8. Hirsch A., Nijveldt R., van der Vleuten P.A., Biemond B.J., Doevendans P.A., van Rossum A.C., et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial-a prospective, multicenter, randomized trial. Am. Heart J. 152 (2006) 434-441
9. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
10. Iba O., Matsubara H., Nozawa Y., Fujiyama S., Amano K., Mori Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106 (2002) 2019-2025
11. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
12. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1185-1189
13. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
14. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3422-3427
15. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
16. Kurata H., Lee H.J., McClanahan T., Coffman R.L., O'Garra A., and Arai N. Friend of GATA is expressed in naive Th cells and functions as a repressor of GATA-3-mediated Th2 cell development. J. Immunol. 168 (2002) 4538-4545
17. Hatzopoulos A.K., Folkman J., Vasile E., Eiselen G.K., and Rosenberg R.D. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125 (1998) 1457-1468
18. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 (2003) 3115-3121
19. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
20. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
21. Elsheikh E., Uzunel M., He Z., Holgersson J., Nowak G., and Sumitran-Holgersson S. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106 (2005) 2347-2355
22. Rafii S., Shapiro F., Rimarachin J., Nachman R.L., Ferris B., Weksler B., et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 84 (1994) 10-19
23. Harraz M., Jiao C., Hanlon H.D., Hartley R.S., and Schatteman G.C. CD34-blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
24. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
25. Ott I., Keller U., Knoedler M., Gotze K.S., Doss K., Fischer P., et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J. 19 (2005) 992-994
26. Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112
27. Burger P.E., Coetzee S., McKeehan W.L., Kan M., Cook P., Fan Y., et al. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100 (2002) 3527-3535
28. Li T.S., Hamano K., Nishida M., Hayashi M., Ito H., Mikamo A., et al. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H931-H937
29. Fernandez Pujol B., Lucibello F.C., Gehling U.M., Lindemann K., Weidner N., Zuzarte M.L., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65 (2000) 287-300
30. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93 (2003) 1023-1025
31. Rookmaaker M.B., Vergeer M., van Zonneveld A.J., Rabelink T.J., and Verhaar M.C. Endothelial progenitor cells: mainly derived from the monocyte/macrophage-containing CD34-mononuclear cell population and only in part from the hematopoietic stem cell-containing CD34+ mononuclear cell population. Circulation 108 (2003) e150 [author reply e]
32. Nakul-Aquaronne D., Bayle J., and Frelin C. Coexpression of endothelial markers and CD14 by cytokine mobilized CD34+ cells under angiogenic stimulation. Cardiovasc. Res. 57 (2003) 816-823
33. Ho M.K., and Springer T.A. Mac-1 antigen: quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J. Immunol. 128 (1982) 2281-2286
34. Fleming T.J., Fleming M.L., and Malek T.R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151 (1993) 2399-2408
35. Schmeisser A., Garlichs C.D., Zhang H., Eskafi S., Graffy C., Ludwig J., et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 49 (2001) 671-680
36. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
37. Tateno K., Minamino T., Toko H., Akazawa H., Shimizu N., Takeda S., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 98 (2006) 1194-1202
38. Takahashi M., Li T.S., Suzuki R., Kobayashi T., Ito H., Ikeda Y., et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H886-H893
39. Vandervelde S., van Luyn M.J., Tio R.A., and Harmsen M.C. Signaling factors in stem cell-mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39 (2005) 363-376
40. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116 (2006) 1865-1877
41. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052